The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

The small UK biotechnology firm Henderson Morley has filed a notice of intention to call in the administrators following its failure to secure the divestment of its ICVT (Ionic Contra Viral Therapy) portfolio to KMS Therapeutics, resulting in a suspension of its shares on London's AIM.

CellStain Technologies believes it has created a staining technique that emphasizes only malignant cells in a diagnostic sample, promising to take some of the subjectivity out of cancer screening.